SOLV Solventum
- 59.860
- -0.590-0.98%
- 59.860
- 0.0000.00%
Solventum News
3M has fully restructured, and its stock price regains potential for growth
3M, which has been hit by the market, is undergoing major changes, including divesting its healthcare division and resolving litigation issues, making it a more flexible company.
Is 3M Spinoff Solventum a Buy? (And What It Means for 3M Investors)
It's always interesting when a new company comes to market and doubly interesting when it's a spinoff. In reality, two new companies came out of the spinoff of Solventum (SOLV -1.41%) and 3M (MMM 3.58%) -- a newly created healthcare company and an industrial conglomerate without a healthcare business.
3M's Stock Rises With Upgrade From Vertical Research
The 3M Dividend Cut Is Here. It's Big.
Post-it maker 3M declared a dividend of 70 cents, down from the prior quarter's $1.51 payout.
Decoding Solventum Corp (SOLV): A Strategic SWOT Insight
Solventum | 10-Q: Quarterly report
Solventum Initiated at Neutral by B of A Securities
Solventum Initiated at Neutral by B of A Securities
Solventum (SOLV.US) was first covered by B of A Securities, which gave it a neutral rating, with a target price of $70.00.
Solventum (SOLV.US) was first covered by B of A Securities, which gave it a neutral rating, with a target price of $70.00.
B of A Securities Initiates Coverage On Solventum With Neutral Rating, Announces Price Target of $70
B of A Securities analyst Travis Steed initiates coverage on Solventum (NYSE:SOLV) with a Neutral rating and announces Price Target of $70.
Solventum Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/10/2024 7.86% B of A Securities → $70 Initiates Coverage On → Neutral 04/10/2024 7.86% Morgan Stanley →
Maintaining Hold on Solventum: A Cautious Outlook on Long-Term Turnaround and Growth Prospects
Solventum Reports Earnings. There Will Be No Dividend. -- Barrons.com
Al Root Solventum, the 3M healthcare business, reported a better-than-expected first-quarter profit on Thursday. What the company said about capital allocation looks to be the bigger deal. Solventum
Solventum Q1 Adjusted Earnings Decline, Net Sales Increase
Solventum (SOLV) reported Q1 adjusted earnings Thursday of $2.08 per diluted share, down from $2.19 a year earlier. Two analysts surveyed by Capital IQ expected $1.75. Net sales for the quarter ended
Solventum Q1 2024 Adj EPS $2.08 Beats $1.75 Estimate, Sales $2.016B Miss $2.017B Estimate
Solventum Q1 2024 Adj EPS $2.08 Beats $1.75 Estimate, Sales $2.016B Miss $2.017B Estimate
Solventum Sees 2024 Adj EPS $6.10-Adj EPS $6.40 >SOLV
Solventum Sees 2024 Adj EPS $6.10-Adj EPS $6.40 >SOLV
Solventum 1Q EPS $1.37 >SOLV
Solventum 1Q EPS $1.37 >SOLV
Earnings Flash (SOLV) SOLVENTUM Reports Q1 EPS $2.08, Vs. Street Est of $1.75
06:51 AM EDT, 05/09/2024 (MT Newswires) -- Earnings Flash (SOLV) SOLVENTUM Reports Q1 EPS $2.08, vs. Street Est of $1.75
Solventum Reports First Quarter 2024 Financial Results and Capital Allocation Update
Press Release: Solventum Reports First Quarter 2024 Financial Results and Capital Allocation Update
Solventum Reports First Quarter 2024 Financial Results and Capital Allocation Update PR Newswire ST. PAUL, Minn., May 9, 2024 -- Completed spin-off from 3M and began trading on April 1, 2024
Arm, Robinhood, Airbnb, AppLovin, Beyond Meat, SolarEdge, Duolingo, and More Stock Market Movers
The fiscal 2025 forecast from chip-design company Arm Holdings disappoints, Robinhood Markets posts an earnings beat and a surge in new deposits, and Airbnb's revenue outlook for the second quarter misses expectations.
Analysis
Price Target
No Data
